-DOCSTART- -X- O
Heparan -X- _ O
sulfate -X- _ O
proteoglycans -X- _ O
( -X- _ O
HSPG -X- _ O
) -X- _ O
are -X- _ O
composed -X- _ O
of -X- _ O
unbranched -X- _ O
, -X- _ O
negatively -X- _ O
charged -X- _ O
heparan -X- _ O
sulfate -X- _ O
( -X- _ O
HS -X- _ O
) -X- _ O
polysaccharides -X- _ O
attached -X- _ O
to -X- _ O
a -X- _ O
variety -X- _ O
of -X- _ O
cell -X- _ O
surface -X- _ O
or -X- _ O
extracellular -X- _ O
matrix -X- _ O
proteins. -X- _ O
Widely -X- _ O
expressed -X- _ O
, -X- _ O
they -X- _ O
mediate -X- _ O
many -X- _ O
biological -X- _ O
activities -X- _ O
, -X- _ O
including -X- _ O
angiogenesis -X- _ O
, -X- _ O
blood -X- _ O
coagulation -X- _ O
, -X- _ O
developmental -X- _ O
processes -X- _ O
, -X- _ O
and -X- _ O
cell -X- _ O
homeostasis. -X- _ O
HSPG -X- _ O
are -X- _ O
highly -X- _ O
sulfated -X- _ O
and -X- _ O
broadly -X- _ O
used -X- _ O
by -X- _ O
a -X- _ O
range -X- _ O
of -X- _ O
pathogens -X- _ O
, -X- _ O
especially -X- _ O
viruses -X- _ O
, -X- _ O
to -X- _ O
attach -X- _ O
to -X- _ O
the -X- _ O
cell -X- _ O
surface. -X- _ O
In -X- _ O
this -X- _ O
review -X- _ O
, -X- _ O
we -X- _ O
summarize -X- _ O
the -X- _ O
current -X- _ O
knowledge -X- _ O
on -X- _ O
HSPGâ€“virus -X- _ B-Patient
interactions -X- _ I-Patient
and -X- _ O
distinguish -X- _ O
viruses -X- _ B-Comparison
with -X- _ I-Comparison
established -X- _ I-Comparison
HS -X- _ I-Comparison
binding -X- _ I-Comparison
, -X- _ I-Comparison
viruses -X- _ I-Comparison
that -X- _ I-Comparison
bind -X- _ I-Comparison
HS -X- _ I-Comparison
only -X- _ I-Comparison
after -X- _ I-Comparison
intra-host -X- _ I-Comparison
or -X- _ I-Comparison
cell -X- _ I-Comparison
culture -X- _ I-Comparison
adaptation -X- _ I-Comparison
, -X- _ I-Comparison
and -X- _ I-Comparison
finally -X- _ I-Comparison
, -X- _ I-Comparison
viruses -X- _ I-Comparison
whose -X- _ I-Comparison
dependence -X- _ I-Comparison
on -X- _ I-Comparison
HS -X- _ I-Comparison
for -X- _ I-Comparison
infection -X- _ I-Comparison
is -X- _ O
debated. -X- _ O
We -X- _ O
also -X- _ O
provide -X- _ O
an -X- _ O
overview -X- _ O
of -X- _ O
the -X- _ O
antiviral -X- _ B-Intervention
compounds -X- _ I-Intervention
designed -X- _ O
to -X- _ O
interfere -X- _ O
with -X- _ O
HS -X- _ O
binding. -X- _ O
Many -X- _ O
questions -X- _ O
remain -X- _ O
about -X- _ O
the -X- _ O
true -X- _ O
importance -X- _ O
of -X- _ O
these -X- _ O
receptors -X- _ O
in -X- _ O
vivo -X- _ O
, -X- _ O
knowledge -X- _ O
that -X- _ O
is -X- _ O
critical -X- _ O
for -X- _ O
the -X- _ O
design -X- _ O
of -X- _ O
future -X- _ O
antiviral -X- _ O
therapies -X- _ O
. -X- _ O

